Matinas Biopharma (MTNB) Stock Chart & Stock Price History $0.81 +0.05 (+6.70%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.81 -0.01 (-0.74%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Matinas Biopharma Stock Price Performance The Matinas Biopharma (MTNB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 59.22%. In the past month, the stock has increased 36.47%, reflecting recent market activity. As of the latest close, Matinas Biopharma traded at $0.81 with a market cap of $4.13 million and volume of 23,744 shares. Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.70%1 Month Performance+36.47%3 Month Performance+35.18%Year-To-Date Performance+59.22% MTNB Stock Chart for Saturday, May, 24, 2025 MTNB Chart by TradingView Matinas Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$0.79$0.81+3.18%$0.82$0.7923,744 shs$4.13 million05/22/2025$0.77$0.79+2.21%$0.83$0.7445,544 shs$4.00 million05/21/2025$0.76$0.77+1.30%$0.86$0.73135,408 shs$3.92 million05/20/2025$0.76$0.76-0.12%$0.79$0.7342,753 shs$3.87 million05/19/2025$0.87$0.76-12.83%$0.86$0.75200,307 shs$3.87 million05/16/2025$0.77$0.87+13.38%$0.93$0.67494,649 shs$4.44 million05/15/2025$0.69$0.77+11.97%$0.79$0.68301,324 shs$3.92 million05/14/2025$0.65$0.69+5.27%$0.75$0.64154,059 shs$3.50 million05/13/2025$0.63$0.65+3.50%$0.69$0.62108,268 shs$3.32 million05/12/2025$0.71$0.63-10.47%$0.69$0.60228,262 shs$3.21 million Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$0.69$0.71+2.92%$0.84$0.64798,291 shs$3.59 million05/08/2025$0.71$0.69-3.25%$0.74$0.6580,492 shs$3.49 million05/07/2025$0.64$0.71+11.32%$0.71$0.6292,761 shs$3.60 million05/06/2025$0.64$0.64-0.59%$0.64$0.6138,519 shs$3.24 million05/05/2025$0.61$0.64+4.89%$0.65$0.5926,664 shs$3.26 million05/02/2025$0.62$0.61-1.61%$0.65$0.5942,998 shs$3.10 million05/01/2025$0.59$0.62+4.91%$0.65$0.5751,784 shs$3.15 million04/30/2025$0.64$0.59-8.23%$0.64$0.5954,689 shs$3.01 million04/29/2025$0.64$0.64+0.47%$0.65$0.6115,088 shs$3.28 million04/28/2025$0.67$0.64-4.33%$0.66$0.6053,034 shs$3.26 million04/25/2025$0.60$0.67+12.61%$0.67$0.59112,638 shs$3.41 million04/24/2025$0.59$0.60+1.71%$0.60$0.5719,587 shs$3.03 million04/23/2025$0.60$0.59-2.48%$0.60$0.5621,806 shs$2.98 million Related Companies TRIB Stock Price Chart COCP Stock Price Chart RLYB Stock Price Chart ERNA Stock Price Chart ABP Stock Price Chart EDSA Stock Price Chart MBRX Stock Price Chart UBX Stock Price Chart MEIP Stock Price Chart UPXI Stock Price Chart Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:MTNB) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matinas Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Matinas Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MTNB Stock Free MTNB Stock Alerts